Corporate deck · August 2026
The full corporate investor presentation for Zentek Ltd. — one model, three platforms, one deep science foundation. Information as of August 10, 2026 except as otherwise noted.
The deck at a glance
A 21-slide walk through the strategy, the Albany material, the graphene coatings revenue engine, Triera biosciences, and the investment case — current as of the dates noted on each slide.
Inside the deck
The corporate deck is organized around the one-model, three-platform story and the investment case behind it.
Zentek at a glance and the capital structure — Albany as the principal critical mineral asset, with ZenGUARD and the R&D pipeline providing support and optionality.
Company overviewThe critical mineral foundation — the PEA modelled at 5N+ purity, the Constance Lake First Nation benefit sharing, deposit-to-demand integration, and premium specification at premium pricing.
Albany overviewStrategic Graphite Partners — the U.S. joint venture built to bring Albany graphite into defence and nuclear energy — and the critical path running engineering and permitting in parallel.
Albany overviewRevenue today: the product lines across masks, filters and filtration media, the production facility behind them, and the development-on-demand model that generates the next ones.
Graphene platformBeyond carbon — batteries and coatings in third-party characterization, plus Triera's 20-year exclusive McMaster University aptamer licence spanning diagnostic, therapeutic and CRO applications.
Triera overviewWhat's ahead across Albany and ZenGUARD, and the investment highlights behind a funded opportunity set. Slide 2 sets out the forward-looking disclosure governing every figure in the deck.
Investor overviewGet the deck
The complete August 2026 investor presentation is available as a PDF — best viewed on desktop. For investor relations questions, reach the IR team directly.
Important information
This presentation is for informational purposes only. It does not constitute an offer to sell or a solicitation of an offer to buy any securities. Information as of August 10, 2026 except as otherwise noted. Forward-looking information is subject to risks and uncertainties — see slide 2 of the presentation for full disclosure. Not investment advice. Zentek Ltd. (TSX-V: ZEN).